Roisin E. O’Cearbhaill

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH)

(2023)10.1158/1078-0432.c.6533210.v1

Top 100%

0DataRank

Top 100%0 citations

James M. Ford, Peter J. O’Dwyer, Geoffrey I. Shapiro, Lisa M. McShane, Boris Freidlin +18 more

Papers

Driven by 71 papers — median percentile 0. Top paper: “Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002)”.

Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002)

Gynecologic Oncology(2020)10.1016/j.ygyno.2019.12.034

N/A

5.8DataRank · unranked

155 citations

Wei Deng, Michael Frumovitz, Natália Buza, Stefania Bellone, Warner K. Huh +7 more

Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: phase 1/2 trial interim results

Nature Medicine(2023)10.1038/s41591-023-02452-y

N/A

2.2DataRank · unranked

106 citations

Marcus O. Butler, Roisin E. O’Cearbhaill, David Y. Oh, Melissa L. Johnson, Kevin Zikaras +10 more

Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.04.012

N/A

1.3DataRank · unranked

36 citations

José Alejandro Pérez Fidalgo, Bradley J. Monk, Ignacio Tusquets, Colleen McCormick, José Fuentes +20 more

National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH)

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3334

N/A

1.3DataRank · unranked

59 citations

James M. Ford, Peter J. O’Dwyer, Geoffrey I. Shapiro, Lisa M. McShane, Boris Freidlin +18 more

Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008)

Gynecologic Oncology Reports(2020)10.1016/j.gore.2019.100532

N/A

0.891DataRank · unranked

17 citations

Virginia L. Filiaci, Stefania Bellone, Roisin E. O’Cearbhaill, Elena Ratner, Cara Mathews +7 more

Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: Going to the next level – A Memorial Sloan Kettering Cancer Center study

Gynecologic Oncology(2023)10.1016/j.ygyno.2022.12.023

N/A

0.835DataRank · unranked

20 citations

Erin McMinn, Effi Yeoshoua, Thomas Boerner, Qin Zhou, Alexia Iasonos +13 more

Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses

Nature Medicine(2024)10.1038/s41591-024-02942-7

N/A

0.790DataRank · unranked

26 citations

Beryl Manning‐Geist, Qin Zhou, Tara E. Soumerai, Aliya Holland, Arnaud Da Cruz Paula +23 more

Cervical cancer treatment update: A Society of Gynecologic Oncology clinical practice statement

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.10.017

N/A

0.494DataRank · unranked

26 citations

Leslie M. Randall, Fumiko Chino, Bradley J. Monk, John Farley, Roisin E. O’Cearbhaill +1 more

Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.03.009

N/A

0.473DataRank · unranked

7 citations

Bhavana Pothuri, Ana Oaknin, Whitney S. Graybill, Ana Beatriz Sánchez, Colleen McCormick +15 more

Folate receptor alpha expression in low-grade serous ovarian cancer: Exploring new therapeutic possibilities

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.06.008

N/A

0.457DataRank · unranked

20 citations

Mackenzie W. Sullivan, Qin Zhou, Alexia Iasonos, Pier Selenica, Chrystal Stallworth +9 more

Vaccination with folate receptor-alpha peptides in patients with ovarian cancer following response to platinum-based therapy: A randomized, multicenter clinical trial

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.07.675

N/A

0.406DataRank · unranked

9 citations

Roisin E. O’Cearbhaill, Matthew S. Block, Erika Hamilton, Jason Konner, Keith L. Knutson +5 more

Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancer

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.10.087

N/A

0.385DataRank · unranked

12 citations

Sushmita Gordhandas, Dilip D. Giri, Alexia Iasonos, Qin Zhou, Jeffrey Girshman +12 more

Baseline risk of hematologic malignancy at initiation of frontline PARP inhibitor maintenance for BRCA1/2-associated ovarian cancer

Gynecologic Oncology Reports(2021)10.1016/j.gore.2021.100873

N/A

0.385DataRank · unranked

12 citations

Duaa H. Al-Rawi, Ying Liu, Maria M. Rubinstein, Claire F. Friedman, Raajit K. Rampal +4 more

Inflammatory markers in gynecologic oncology patients hospitalized with COVID-19 infection

Gynecologic Oncology(2020)10.1016/j.ygyno.2020.09.036

N/A

0.373DataRank · unranked

11 citations

Olivia D. Lara, Roisin E. O’Cearbhaill, Anne Knisely, Jennifer McEachron, Lisa Gabor +12 more

Pattern of disease and response to pembrolizumab in recurrent cervical cancer

Gynecologic Oncology Reports(2021)10.1016/j.gore.2021.100831

N/A

0.345DataRank · unranked

9 citations

Olga T. Filippova, Sara A. Hayes, Nadeem R. Abu‐Rustum, Carol Aghajanian, Vance Broach +14 more

Factors associated with an inconclusive result from commercial homologous recombination deficiency testing in ovarian cancer

Cancer(2024)10.1002/cncr.35523

N/A

0.330DataRank · unranked

8 citations

Stephen Graves, Anusha Adkoli, Qin Zhou, Alexia Iasonos, Lora H. Ellenson +8 more

Tyrosine kinase inhibitor toxicities: A society of gynecologic oncology review and recommendations

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.05.007

N/A

0.312DataRank · unranked

7 citations

Erin K. Crane, June Y. Hou, John Nakayama, Jennifer MacDonald, Kathleen Lutz +3 more

Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non–Small Cell Lung Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1591

N/A

0.292DataRank · unranked

6 citations

Gilberto Lopes, T. Jeroen N. Hiltermann, Ramaswamy Govindan, Liza C. Villaruz, Emiliano Calvo +19 more

Basket study of oral progesterone antagonist onapristone extended release in progesterone receptor-positive recurrent granulosa cell, low-grade serous ovarian cancer, or endometrioid endometrial cancer

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.06.026

N/A

0.269DataRank · unranked

5 citations

Lindsey Finch, Alexia Iasonos, Qin Zhou, Jeffrey Girshman, Rashmi Chhetri-Long +14 more

A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.06.021

N/A

0.241DataRank · unranked

4 citations

Austin Miller, Robert A. Soslow, Heather A. Lankes, Deborah F. DeLair, Sheila Segura +10 more

Immunotherapy toxicities: An SGO clinical practice statement

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.05.003

N/A

0.241DataRank · unranked

4 citations

Leslie H. Clark, Ramez N. Eskander, Stéphanie Gaillard, John W. Moroney, Elena Pereira +2 more

Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series

International Journal of Gynecological Cancer(2024)10.1136/ijgc-2023-004842

N/A

0.165DataRank · unranked

2 citations

Victoria Wan, Michael Finlan, Qin Zhou, Alexia Iasonos, Oliver Zivanovic +14 more

Infections in Patients with Solid Tumors Undergoing Adoptive Cellular Therapy

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.02.017

N/A

0.165DataRank · unranked

2 citations

Jumanah N Algazaq, Kenneth Seier, Rhoena Desir-Camille, Li-Xuan Qin, Olayode Babatunde +12 more

Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.05.013

N/A

0.104DataRank · unranked

1 citations

Austin Miller, Judith A. Smith, Stuart M. Lichtman, Michael A. Bookman, Carol Aghajanian +17 more

Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.11.019

N/A

0DataRank · unranked

19 citations

Pier Selenica, Thomas Boerner, Kara Long Roche, Yonghong Xiao, Tiffany Sia +23 more

Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide management

Gynecologic Oncology(2023)10.1016/j.ygyno.2022.12.022

N/A

0DataRank · unranked

11 citations

Beryl Manning‐Geist, Andrea Knežević, Luxue Deng, Maria Bromberg, Samuel A. Funt +13 more

Morbidity after secondary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for ovarian cancer: An analysis of a randomized phase II trial

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.02.003

N/A

0DataRank · unranked

10 citations

Qin Zhou, Alexia Iasonos, Lea A. Moukarzel, Kimberly Dessources, Krysten Soldan +11 more

Germline drivers of gynecologic carcinosarcomas

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.04.024

N/A

0DataRank · unranked

8 citations

Sushmita Gordhandas, Ozge Ceyhan‐Birsoy, Yelena Kemel, Anna Maio, Erin Salo‐Mullen +22 more

Dual targeting ovarian cancer by Muc16 CAR-T cells secreting a bispecific T cell engager antibody for an intracellular tumor antigen WT1

Research Square(2023)10.21203/rs.3.rs-2887299/v1

N/A

0DataRank · unranked

4 citations

Leila Peraro, Jeremy Meyerberg, Tatyana Korontsvit, Manish Malviya, Thomas J. Gardner +6 more

Data from National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH)

(2023)10.1158/1078-0432.c.6533210.v1

Top 100%

0DataRank

Top 100%0 citations

James M. Ford, Peter J. O’Dwyer, Geoffrey I. Shapiro, Lisa M. McShane, Boris Freidlin +18 more

Data from National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH)

(2023)10.1158/1078-0432.c.6533210

Top 100%

0DataRank

Top 100%0 citations

James M. Ford, Peter J. O’Dwyer, Geoffrey I. Shapiro, Lisa M. McShane, Boris Freidlin +18 more

Data from National Cancer Institute Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH)

(2023)10.1158/1078-0432.c.6533210.v2

Top 100%

0DataRank

Top 100%0 citations

James M. Ford, Peter J. O’Dwyer, Geoffrey I. Shapiro, Lisa M. McShane, Boris Freidlin +18 more

Germline variants in non-BRCA1/2 homologous recombination-related genes and ovarian cancer: Analysis of tumor phenotype and survival.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5565

N/A

0DataRank · unranked

0 citations

Pier Selenica, Thomas Boerner, Yonghong Xiao, Tiffany Sia, Margaret Sheehan +15 more

Secondary cytoreductive surgery and oncologic outcomes in the era of targeted maintenance therapy for recurrent, platinum-sensitive ovarian cancer

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.03.006

N/A

0DataRank · unranked

4 citations

Clarissa Lam, Qin Zhou, Alexia Iasonos, Rachel N. Grisham, William P. Tew +7 more

Ocular side effects of anticancer agents used in the treatment of gynecologic cancers

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.06.003

N/A

0DataRank · unranked

3 citations

Sophie Broderick, Jasmine H. Francis, Roisin E. O’Cearbhaill, Julia Canestraro, Fionnuala Crowley

Association between genomic instability score and progression-free/overall survival in patients with newly diagnosed non-BRCA1/2 ovarian cancer

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.11.011

N/A

0DataRank · unranked

3 citations

Mackenzie W. Sullivan, Anusha Adkoli, Qin Zhou, Alexia Iasonos, Pier Selenica +10 more

Molecular and microenvironmental landscapes of human papillomavirus-independent invasive squamous cell carcinoma of the vulva

International Journal of Gynecological Cancer(2024)10.1016/j.ijgc.2024.100051

N/A

0DataRank · unranked

2 citations

Olga T. Filippova, Arnaud Da Cruz Paula, Juan Blanco-Heredia, Hunter Green, Vance Broach +7 more

Use of romiplostim for antineoplastic therapy-induced thrombocytopenia in gynecologic and breast cancers

Gynecologic Oncology Reports(2024)10.1016/j.gore.2024.101399

N/A

0DataRank · unranked

1 citations

Roisin E. O’Cearbhaill, Qin Zhou, Alexia Iasonos, Simon Mantha, Jeffrey I. Zwicker +2 more

Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial

Nature Communications(2025)10.1038/s41467-024-55200-2

N/A

0DataRank · unranked

18 citations

Dmitriy Zamarin, Wei Deng, Heather A. Lankes, Giulio Pesci, Hayeon Kim +19 more

Dupilumab for bullous pemphigoid related to immune checkpoint inhibitors: a retrospective case series

The Oncologist(2025)10.1093/oncolo/oyaf208

N/A

0DataRank · unranked

12 citations

Andrea P. Moy, Stephen W. Dusza, Alison J. Moskowitz, Gopa Iyer, Afsheen N. Iqbal +8 more

A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology/GOG study

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.03.003

N/A

0DataRank · unranked

9 citations

Michael W. Sill, Paola A. Gehrig, Jason D. Merker, David L. Corcoran, Adam D. Pfefferle +15 more

Basket study of oral progesterone antagonist onapristone extended-release in combination with anastrozole in progesterone receptor-positive recurrent adult-type granulosa cell tumor of the ovary

International Journal of Gynecological Cancer(2025)10.1016/j.ijgc.2024.100005

N/A

0DataRank · unranked

3 citations

Sarah Andres, Alexia Iasonos, Qin Zhou, Jeffrey Girshman, Rashmi Chhetri-Long +15 more

Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody–drug conjugate

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.03.023

N/A

0DataRank · unranked

2 citations

Matthew Flint, M. Herman Chui, Jason Konner, Claire F. Friedman, Angela K. Green +14 more

Image guided brachytherapy quality assurance on NRG GY017 investigating immunotherapy in addition to chemoradiation for locally advanced cervical cancer

Brachytherapy(2025)10.1016/j.brachy.2025.09.011

N/A

0DataRank · unranked

2 citations

Wei Deng, Dmitriy Zamarin, Ying Xiao, Junzo Chino, Stanley Benedict +18 more

Anaplastic carcinoma of the ovary: A single-institution experience and molecular analysis

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.03.021

N/A

0DataRank · unranked

2 citations

M. Herman Chui, Pier Selenica, Kara Long Roche, Yukio Sonoda, Rachel N. Grisham +6 more

Prognostic value of “aggressive” histology in surgically staged clinically uterine-confined endometrial carcinoma

International Journal of Gynecological Cancer(2025)10.1016/j.ijgc.2025.102656

N/A

0DataRank · unranked

2 citations

Jennifer J. Mueller, Yukio Sonoda, Amir Momeni Boroujeni, Vicky Makker, Roisin E. O’Cearbhaill +4 more

Interstitial lung disease in targeted therapies: A Society of Gynecologic Oncology clinical practice statement

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.09.010

N/A

0DataRank · unranked

1 citations

Ira Winer, Christopher M. Tarney, Stéphanie Gaillard, Roisin E. O’Cearbhaill, Charles A. Powell

Updates in US Food and Drug Administration approvals for poly-ADP-ribose polymerase inhibitors in Ovarian Cancer: A society of gynecologic oncology clinical practice review

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.11.020

N/A

0DataRank · unranked

0 citations

Bhavana Pothuri, Karen A. Cadoo, Yvette Drew, Rachel Miller-Garcia, Deborah K. Armstrong +2 more

A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers

Gynecologic Oncology(2020)10.1016/j.ygyno.2020.10.019

N/A

0DataRank · unranked

16 citations

Rachel N. Grisham, Karen A. Cadoo, Chrisann Kyi, William P. Tew, Claire F. Friedman +14 more

Impact of Provider Imaging Practices on Survival Outcomes in Advanced Ovarian Cancer

Journal of the National Comprehensive Cancer Network(2020)10.6004/jnccn.2019.7376

N/A

0DataRank · unranked

5 citations

Deborah Korenstein, Carol Aghajanian, Brooke Barrow, Michael Curry, Roisin E. O’Cearbhaill +1 more

Enhancing Delivery of Small‐Molecule‐ and Cell‐Based Therapies for Ovarian Cancer Using Advanced Delivery Strategies

Advanced Therapeutics(2020)10.1002/adtp.202000144

N/A

0DataRank · unranked

3 citations

Roisin E. O’Cearbhaill, Robert Wylie, Saoirse O'Mahony, Michael O’Dwyer, Garry P. Duffy +2 more

A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab

Cancer Discovery(2021)10.1158/2159-8290.cd-21-0407

N/A

0DataRank · unranked

570 citations

Marjorie G. Zauderer, Isabelle Rivière, Stephen B. Solomon, Valerie W. Rusch, Roisin E. O’Cearbhaill +25 more

Exploiting somatic alterations as therapeutic targets in advanced and metastatic cervical cancer

Cancer Treatment Reviews(2021)10.1016/j.ctrv.2021.102225

N/A

0DataRank · unranked

25 citations

Roisin E. O’Cearbhaill, Dearbhaile Catherine Collins, Fionnuala Crowley

COVID-19 outcomes of patients with gynecologic cancer in New York City: An updated analysis from the initial surge of the pandemic

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.12.004

N/A

0DataRank · unranked

19 citations

Maria Smith, Yuyan Wang, Roisin E. O’Cearbhaill, Stephanie V. Blank, Valentin Kolev +13 more

Quaternary and beyond cytoreduction: An updated and expanded analysis

Gynecologic Oncology Reports(2021)10.1016/j.gore.2021.100851

N/A

0DataRank · unranked

2 citations

S. Dennis, Kara Long Roche, Oliver Zivanovic, Yukio Sonoda, Ginger J. Gardner +4 more

Evaluating the role of aromatase inhibitors (AIs) in the treatment of endometrial stromal sarcomas (ESS).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5575

N/A

0DataRank · unranked

1 citations

Karen A. Cadoo, Sarah Chiang, Jennifer J. Mueller, Martee L. Hensley, Roisin E. O’Cearbhaill +1 more

Gastric-type adenocarcinoma of the cervix: Clinical outcomes and genomic drivers

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.10.003

N/A

0DataRank · unranked

48 citations

Dib Sassine, Alli Straubhar, Aaron Praiss, Carol Aghajanian, Kaled M. Alektiar +17 more

Outcomes and long-term follow-up by treatment type for patients with advanced-stage ovarian cancer managed at a tertiary cancer center: A Memorial Sloan Kettering Cancer Center Team Ovary study

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.12.009

N/A

0DataRank · unranked

18 citations

Kelly Shay, Qin Zhou, Alexia Iasonos, Yukio Sonoda, Ginger J. Gardner +7 more

Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.11.028

N/A

0DataRank · unranked

23 citations

Eric Rios Doria, Jason Konner, Stuart M. Lichtman, Qin Zhou, Alexia Iasonos +18 more

Hyperthermic intraperitoneal chemotherapy (HIPEC) with carboplatin induces distinct transcriptomic changes in ovarian tumor and normal tissues

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.02.022

N/A

0DataRank · unranked

15 citations

Lorenzo Ferrando, Higinio Dopeso, Anthe A. Stylianou, Thais Basili, Fresia Pareja +14 more

Small cell neuroendocrine carcinoma of the cervix: Analysis of prognostic factors and patterns of metastasis

Gynecologic Oncology Reports(2022)10.1016/j.gore.2022.101058

N/A

0DataRank · unranked

11 citations

Brooke A. Schlappe, Qin Zhou, Alexia Iasonos, Mario M. Leitão, Kay J. Park +8 more

Ten-year conditional probability of survival for patients with ovarian cancer: A new metric tailored to Long-term survivors

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.11.030

N/A

0DataRank · unranked

11 citations

Olga T. Filippova, Sushmita Gordhandas, Anjile An, Alli Straubhar, Oliver Zivanovic +9 more

Shared decision making for patients with breast and gynecologic malignancies undergoing chemotherapy associated with persistent alopecia

Gynecologic Oncology Reports(2022)10.1016/j.gore.2022.101095

N/A

0DataRank · unranked

4 citations

Anastasia Navitski, Claire F. Friedman, Donald Chan, Shari Goldfarb, Mario E. Lacouture +2 more

Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials

Molecular Therapy(2022)10.1016/j.ymthe.2022.12.006

N/A

0DataRank · unranked

11 citations

Jing Yao, Kimberley House, Lisa Duffy, Prasad S. Adusumilli, Rachel K. Beyer +26 more

Evaluating the role of aromatase inhibitors in the treatment of low-grade endometrial stromal sarcomas

Gynecologic Oncology Reports(2022)10.1016/j.gore.2022.100980

N/A

0DataRank · unranked

4 citations

Karen A. Cadoo, Sarah Chiang, Diana Mandelker, Raazi Bajwa, Alexia Iasonos +5 more

Safety and efficacy of an outpatient 12-step desensitization protocol for antineoplastic agents

International Journal of Gynecological Cancer(2022)10.1136/ijgc-2022-003466

N/A

0DataRank · unranked

6 citations

Olga T. Filippova, Maria J. Kirrane, Mary Orpen, Vianca Almonte, Rachael Thomas +5 more

COVID-19 in patients with gynecologic cancer: A preliminary report from the COVID-19 and Cancer Consortium (CCC19).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.5508

N/A

0DataRank · unranked

0 citations

Lauren S. Prescott, Erika Ruíz‐García, Clara Hwang, Hannah Heilman, Rana R. McKay +13 more

Dual targeting ovarian cancer by Muc16 CAR T cells secreting a bispecific T cell engager antibody for an intracellular tumor antigen WT1

Cancer Immunology Immunotherapy(2023)10.1007/s00262-023-03529-w

N/A

0DataRank · unranked

36 citations

Jeremy Meyerberg, Leila Peraro, Tatyana Korontsvit, Thomas J. Gardner, Manish Malviya +6 more

Novel Therapeutics in Ovarian Cancer: Expanding the Toolbox

Current Oncology(2023)10.3390/curroncol31010007

N/A

0DataRank · unranked

24 citations

Roisin E. O’Cearbhaill, Sara Moufarrij

Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-1078

N/A

0DataRank · unranked

20 citations

Vignesh Ravichandran, Kathryn Miller, Chad Vanderbilt, Qin Zhou, Alexia Iasonos +17 more

Phase I Study of a Multivalent WT1 Peptide Vaccine (Galinpepimut-S) in Combination with Nivolumab in Patients with WT1-Expressing Ovarian Cancer in Second or Third Remission

Cancers(2023)10.3390/cancers15051458

N/A

0DataRank · unranked

20 citations

Sacha Gnjatic, Carol Aghajanian, Jason Konner, Sarah H. Kim, Debra Sarasohn +12 more

Roisin E. O’Cearbhaill

Indexed papers

Top data-sharing exemplar

Papers